Clinical reference
Anticholinergic, anti-Parkinson · Anticholinergic agent, drug-induced dystonic reaction antidote, anti-Parkinson agent · Neurology, Psychiatry, Emergency Medicine
Benztropine mesylate is an anticholinergic agent. Injection: 1 mg/mL (2 mL); Tablets: 0.5, 1, 2 mg. Contraindicated in myasthenia gravis, GI/GU obstruction, untreated narrow-angle glaucoma, and peptic ulcer. Use IV route only when PO and IM are not feasible. May cause anticholinergic side effects, especially constipation and dry mouth. Drug interactions:…